Phase II trial of amrubicin and carboplatin in patients with sensitive or refractory relapsed small-cell lung cancerHIROSE, Takashi; NAKASHIMA, Masanao; SHIRAI, Takao et al.Lung cancer. 2011, Vol 73, Num 3, pp 345-350, issn 0169-5002, 6 p.Article

Oral arsenic trioxide-based regimen as salvage treatment for relapsed or refractory mantle cell lymphomaGILL, H; AU, W. Y; CHEUNG, W. W et al.Annals of oncology. 2014, Vol 25, Num 7, pp 1391-1397, issn 0923-7534, 7 p.Article

Impact of lenalidomide dose on progression-free survival in patients with relapsed or refractory multiple myelomaDIMOPOULOS, M. A; HUSSEIN, M; SWERN, A. S et al.Leukemia. 2011, Vol 25, Num 10, pp 1620-1626, issn 0887-6924, 7 p.Article

Bortezomib Retreatment in Relapsed Multiple Myeloma - Results from a Retrospective Multicentre Survey in Germany and SwitzerlandHRUSOVSKY, I; EMMERICH, B; VON ROHR, A et al.Oncology. 2010, Vol 79, Num 3-4, pp 247-254, issn 0030-2414, 8 p.Article

Treatment of relapsed idiopathic clubfoot by complete subtalar release combined with the ilizarov methodNAKASE, Takanobu; YASUI, Natsuo; OHZONO, Kenji et al.The Journal of foot and ankle surgery. 2006, Vol 45, Num 5, pp 337-341, issn 1067-2516, 5 p.Article

Gemcitabine, cisplatin and methylprednisolone (GEM-P) is an effective salvage regimen in patients with relapsed and refractory lymphomaNG, M; WATERS, J; CUNNINGHAM, D et al.British journal of cancer. 2005, Vol 92, Num 8, pp 1352-1357, issn 0007-0920, 6 p.Article

Carboplatin-based chemotherapy for refractory and recurrent Ewing's tumoursWHELAN, Jeremy S; MCTIERNAN, Anne; KAKOURI, Eleni et al.Pediatric blood & cancer. 2004, Vol 43, Num 3, pp 237-242, issn 1545-5009, 6 p.Article

Flavopiridol treatment of patients aged 70 or older with refractory or relapsed chronic lymphocytic leukemia is a feasible and active therapeutic approachSTEPHENS, Deborah M; RUPPERT, Amy S; BLUM, Kristie et al.Haematologica (Roma). 2012, Vol 97, Num 3, pp 423-427, issn 0390-6078, 5 p.Article

Phase I study of bortezomib plus ICE (BICE) for the treatment of relapsed/refractory Hodgkin lymphomaFANALE, Michelle; FAYAD, Luis; KWAK, Larry W et al.British journal of haematology. 2011, Vol 154, Num 2, pp 284-286, issn 0007-1048, 3 p.Article

Phase I clinical and pharmacokinetic study of a novel schedule of flavopiridol in relapsed or refractory acute leukemiasBLUM, William; PHELPS, Mitch A; JOHNSON, Amy et al.Haematologica (Roma). 2010, Vol 95, Num 7, pp 1098-1105, issn 0390-6078, 8 p.Article

Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma : impact of a dose-modification guidelineRICHARDSON, Paul G; SONNEVELD, Pieter; BLADE, Joan et al.British journal of haematology. 2009, Vol 144, Num 6, pp 895-903, issn 0007-1048, 9 p.Article

Bortezomib and gemcitabine in relapsed or refractory Hodgkin's lymphomaMENDLER, J. H; KELLY, J; FRIEDBERG, J. W et al.Annals of oncology. 2008, Vol 19, Num 10, pp 1759-1764, issn 0923-7534, 6 p.Article

Combination chemotherapy with gemcitabine, oxaliplatin, and paclitaxel in patients with cisplatin-refractory or multiply relapsed germ-cell tumors : a study of the German Testicular Cancer Study GroupBOKEMEYER, C; OECHSLE, K; HONECKER, F et al.Annals of oncology. 2008, Vol 19, Num 3, pp 448-453, issn 0923-7534, 6 p.Article

Phase II trial of irinotecan, cisplatin and mitomycin for relapsed small cell lung cancerFENNELL, Dean A; STEELE, Jeremy P. C; SHAMASH, Jonathan et al.International journal of cancer. 2007, Vol 121, Num 11, pp 2575-2577, issn 0020-7136, 3 p.Article

Current treatment and immunotherapy of Hodgkin's lymphomaKLIMM, Beate; SCHNELL, Roland; DIEHL, Volker et al.Haematologica (Roma). 2005, Vol 90, Num 12, pp 1680-1682, issn 0390-6078, 3 p.Article

Cyclosporin combined with levamisole for refractory or relapsed severe aplastic anaemiaYINGQI SHAO; XINGXIN LI; JUN SHI et al.British journal of haematology. 2013, Vol 162, Num 4, pp 552-555, issn 0007-1048, 4 p.Article

A prospective, international phase 2 study of bortezomib retreatment in patients with relapsed multiple myelomaPETRUCCI, Maria T; GIRALDO, Pilar; MITCHELL, Vivien et al.British journal of haematology. 2013, Vol 160, Num 5, pp 649-659, issn 0007-1048, 11 p.Article

Results of Inotuzumab Ozogamicin, a CD22 Monoclonal Antibody, in Refractory and Relapsed Acute Lymphocytic LeukemiaKANTARJIAN, Hagop; THOMAS, Deborah; FADERL, Stefan et al.Cancer. 2013, Vol 119, Num 15, pp 2728-2736, issn 0008-543X, 9 p.Article

Phase 2 Randomized Study of p53 Antisense Oligonucleotide (Cenersen) Plus Idarubicin With or Without Cytarabine in Refractory and Relapsed Acute Myeloid LeukemiaCORTES, Jorge; KANTARJIAN, Hagop; BALL, Edward D et al.Cancer. 2012, Vol 118, Num 2, pp 418-427, issn 0008-543X, 10 p.Article

Management of relapsed and refractory classical Hodgkin lymphoma in children and adolescentsDAW, Stephen; WYNN, Rob; WALLACE, Hamish et al.British journal of haematology. 2011, Vol 152, Num 3, pp 249-260, issn 0007-1048, 12 p.Article

The Efficacy and Safety of Bortezomib and Dexamethasone as a Maintenance Therapy in Patients With Advanced Multiple Myeloma Who Are Responsive to Salvage Bortezomib-Containing RegimensBENEVOLO, Giulia; LAROCCA, Alessandra; VITOLO, Umberto et al.Cancer. 2011, Vol 117, Num 9, pp 1884-1890, issn 0008-543X, 7 p.Article

Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer : Cancer and Leukemia Group B Study 39902ROCHA-LIMA, C. M; HERNDON, J. E; LEE, M. E et al.Annals of oncology. 2007, Vol 18, Num 2, pp 331-337, issn 0923-7534, 7 p.Article

A phase 2 study of two doses of bortezomib in relapsed or refractory myelomaJAGANNATH, S; BARLOGIE, B; ADAMS, J et al.British journal of haematology. 2004, Vol 127, Num 2, pp 165-172, issn 0007-1048, 8 p.Article

A Phase 2 Study of Epothilone B Analog BMS-247550 (NSC 710428) in Patients With Relapsed Aggressive Non-Hodgkin LymphomasCHURPEK, Jane E; PRO, Barbara; BESIEN, Koen Van et al.Cancer. 2013, Vol 119, Num 9, pp 1683-1689, issn 0008-543X, 7 p.Article

Combination chemotherapy with clofarabine, cyclophosphamide, and etoposide in children with refractory or relapsed haematological malignanciesINABA, Hiroto; BHOJWANI, Deepa; WING LEUNG et al.British journal of haematology. 2012, Vol 156, Num 2, pp 275-279, issn 0007-1048, 5 p.Article